Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion.
The emergence of human immunodeficiency virus type 1 (HIV-1) variants with different sensitivities to serum neutralization and biologic phenotype was studied for 2-5 years after primary HIV-1 infection in 5 subjects. In 3 subjects, the initial virus isolate from seroconversion could be neutralized by autologous serum, but isolates obtained at two subsequent times exhibited reduced sensitivity to serum neutralization, decreased replication in primary macrophages, and increased ability to induce syncytia. Two of these 3 subjects progressed to AIDS and died. Sequential virus isolates from the other 2 subjects showed variability in sensitivity to serum neutralization or biologic features. These patients remained relatively stable in clinical status. Thus, viruses isolated at seroconversion appear to be either non-syncytium-inducing, strong macrophage-tropic, serum neutralization-sensitive phenotypes with stable clinical status or to have escaped neutralization by autologous sera over time, have reduced macrophage tropism and increased syncytia formation, and be associated with disease progression.
Centre for Immunology, St. Vincent's Hospital, Sydney, Australia.
M L
ML
Tsang
L A
LA
Evans
P
P
McQueen
L
L
Hurren
C
C
Byrne
R
R
Penny
B
B
Tindall
D A
DA
Cooper
D000163:Acquired Immunodeficiency Syndrome / Q000821:virology*; D015483:HIV Antibodies / Q000097:blood*; D006679:HIV Seropositivity; D015497:HIV-1 / Q000145:classification / Q000276:immunology*; D006801:Humans; D008297:Male; D009500:Neutralization Tests
D015483:HIV Antibodies